Related Experiment Videos

The global problem of antimicrobial resistance

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|July 1, 1997
PubMed

Insights

Multidrug-resistant Streptococcus pneumoniae and Mycobacterium tuberculosis pose significant threats. Combating antimicrobial resistance requires surveillance and multidisciplinary strategies to address drug inactivation, altered permeability, and target site changes.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Increasing prevalence of multidrug-resistant pathogens like Streptococcus pneumoniae in healthcare settings.
  • The global AIDS pandemic exacerbates the threat of antimicrobial resistance in Mycobacterium tuberculosis.

Purpose of the Study:

  • To highlight the growing concern of antimicrobial resistance.
  • To outline the molecular mechanisms underlying antimicrobial resistance.
  • To emphasize the importance of surveillance and multidisciplinary approaches in combating resistance.

Main Methods:

  • Review of existing literature on antimicrobial resistance.
  • Identification of key resistant pathogens and contributing factors.
  • Analysis of molecular mechanisms of resistance.

Main Results:

  • Streptococcus pneumoniae identified as a significant multidrug-resistant pathogen.
  • Mycobacterium tuberculosis resistance amplified by the AIDS pandemic.
  • Three primary molecular mechanisms of antimicrobial resistance identified: drug inactivation, altered cell permeability, and target site alteration.

Conclusions:

  • Antimicrobial resistance is a serious global health threat requiring urgent attention.
  • Effective containment necessitates robust surveillance systems and collaborative, multidisciplinary strategies.
  • Understanding the molecular basis of resistance is crucial for developing effective interventions.

Related Concept Videos